Venus Remedies Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venus Remedies has submitted the annual disclosure required from promoters and the promoter group under SEBI's takeover regulations, confirming their share encumbrance (pledge) status as of 31st March 2025. The promoter group, led by Managing Director Pawan Chaudhary along with Manu Chaudhary, Akshansh Chaudhary, Peeyush Jain, Ashutosh Jain, and Sonev Pharma Solutions Ltd, declared that no equity shares held by them are currently encumbered or pledged. They also confirmed that no new encumbrances were created or released during FY 2024-25 beyond what was already disclosed earlier in the year. This is essentially a nil-pledge confirmation from the promoters.
This is a routine annual compliance filing and signals that the promoter group has a clean (unpledged) shareholding as of year-end, which is a mildly positive sign for shareholders as it removes concerns about forced selling risk from pledge invocation.